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Summary
Lethal disease due to hepatic periportal fibrosis occurs
in 2%–10% of subjects infected by Schistosoma man-
soni in endemic regions such as Sudan. It is unknown
why few infected individuals present with severe disease,
and inherited factors may play a role in fibrosis devel-
opment. Schistosomamansoni infection levels have been
shown to be controlled by a locus that maps to chro-
mosome 5q31-q33. To investigate the genetic control of
severe hepatic fibrosis (assessed by ultrasound exami-
nation) causing portal hypertension, a segregation anal-
ysis was performed in 65 Sudanese pedigrees from the
same village. Results provide evidence for a codominant
major gene, with .16 as the estimated allele A frequency
predisposing to advanced periportal fibrosis. For AA
males, AA females, and Aa males a 50% penetrance is
reached after, respectively, 9, 14, and 19 years of resi-
dency in the area, whereas for other subjects the pene-
trance remains !.02 after 20 years of exposure. Linkage
analysis performed in four candidate regions shows that
this major locus maps to chromosome 6q22-q23 and
that it is closely linked (multipoint LOD score 3.12) to
the IFN-gR1 gene encoding the receptor of the strongly
antifibrogenic cytokine interferon-g. These results show
that infection levels and advanced hepatic fibrosis in hu-
man schistosomiasis are controlled by distinct loci; they
suggest that polymorphisms within the IFN-gR1 gene
could determine severe hepatic disease due to S. mansoni
infection and that the IFN-gR1 gene is a strong candi-
date for the control of abnormal fibrosis observed in
other diseases.
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Introduction
Schistosomiasis affects 200 million people and is a major
public health problem in many southern countries. The
larvae of Schistosoma mansoni, the most common schis-
tosome species, penetrate the skin of humans in contact
with infested waters. Within a few weeks, the parasites
migrate to the portal and mesenteric veins of their host,
where they mature into either male or egg-laying female
worms. Although most eggs pass into the intestine, a
number of them are taken, by the portal-vein blood flow,
to the liver, where they are lodged in small vessels, caus-
ing inflammatory granuloma. The granuloma may sub-
side, succeeded by tissue repair, which, in certain sub-
jects, leads to extended and irreversible fibrosis denoted
as “Symmers fibrosis” (Symmers 1904; Bogliolo 1954).
Mortality in S. mansoni infections is mainly the conse-
quence of portal-blood hypertension that is caused by
hepatic periportal fibrosis. It is not known why severe
disease occurs only in certain subjects, although it has
been suggested that advanced disease might be more
frequent in subjects with the highest infections (Kloetzel
1962; Cheever 1968; Cook et al. 1974; Arap Siongok
et al. 1976).
Animal studies have indicated that disease develop-
ment is affected by the interleukins (IL), which regulate
the granulomatous response—especially IL-10 (Wynn et
al. 1998), IL-12 (Wynn et al. 1995), and tissue-necrosis
factor TNF-a (Leptak and McKerrow 1997). Fibrosis
following granulomatous inflammation has also been
shown to be dependent on the fibrogenic action of cy-
tokines such as IL-4 (Cheever et al. 1994) and trans-
forming growth factor TGF-b1 (Czaja et al. 1998a) and
on the antifibrogenic effect of interferon-g (IFN-g)
(Czaja et al. 1989b). Interestingly, animal studies indi-
cate that IFN-g is probably not involved in the acute
inflammatory phase of the granuloma but regulates fi-
brosis in the healing phase of the periovular reaction.
The hypothesis that either IFN-g, IL-4, IL-10, IL-12,
TNF-a, or TGF-b plays a similar role in human schis-
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tosomiasis has never been tested, because immunological
studies have not been performed on well-defined fibrosis
phenotypes. Various reports, however, point to IFN-g as
a major antifibrogenic cytokine in tissue fibrosis (Jime-
nez et al. 1984; Duncan and Berman 1985; Tamai et al.
1995), including hepatic fibrosis (Mallat et al. 1995).
In previous studies we have demonstrated that levels
of infection by S. mansoni in a Brazilian populationwere
controlled by a major gene referred to as “SM1” (MIM
181460) (Abel et al. 1991), which we mapped to chro-
mosome 5q31-q33 (Marquet et al. 1996). Since severe
disease in this Brazilian population had been prevented
by repeated chemotherapy, the present study was per-
formed in a Sudanese population that inhabits an en-
demic region and that had never been treated for schis-
tosomiasis, in order to analyze the factors that determine
severe disease in S. mansoni infections. Phenotypes were
assessed by liver and spleen ultrasonography, which has
been shown to be a highly reliable tool for the diagnosis
of Symmers fibrosis (Cerri et al. 1984; Homeida et al.
1988a, 1988b; Abdel-Wahab et al. 1989, 1990; The
Cairo Working Group 1992). The following observa-
tions have suggested that inherited factors might play a
role in advanced fibrosis in this Sudanese population
(Mohamed-Ali et al. 1999): (1) advanced fibrosis was
more frequent in certain families, despite similar epi-
demiological conditions for the whole study population;
and (2) fibrosis grades between parents and children
showed correlation but those among spouses did not.
To test for genetic control of fibrosis, a segregation anal-
ysis was performed on 781 individuals belonging to 65
pedigrees. This analysis provides evidence for the pres-
ence of a major gene referred to as “SM2.” Linkage
analysis was then performed in the following four can-
didate regions:
1. Chromosome region 5q31-q33.—This region con-
tains SM1 and several interleukin genes—including IL-4,
IL-5, and IL-12—that have been shown to play a role
in granuloma formation and/or in fibrosis in experi-
mental animals; this region also has been linked to loci
controlling phenotypes—such as total serum IgE levels
(Marsh et al. 1994; Meyers et al. 1994), familial hy-
pereosinophilia (Rioux et al. 1998), and bronchial hy-
perresponsiveness in asthma (Postma et al. 1995)—that
may be relevant to immunity in schistosomiasis.
2. HLA-TNF region 6p21.—Associations have been
reported between some HLA alleles and hepatosplen-
omegaly in schistosomiasis (Salam et al. 1979; Abaza et
al. 1985; Abdel-Salam et al. 1986; Cabello et al. 1991;
Secor et al. 1996), and TNF-a is an essential cytokine
in the development of schistosome granuloma in mice
(Leptak and McKerrow 1997); furthermore, polymor-
phisms in the promoter of TNF-a have been associated
with both aggravation of immunopathological lesions in
mucocutaneous leishmaniasis (Cabrera et al. 1995) and
an increased risk for cerebral malaria in children infected
by Plasmodium falciparum (McGuire et al. 1994).
3. Chromosome region 12q15.—This region includes
the gene coding for IFN-g, which has also been linked
to both asthma control and serum total IgE levels
(Barnes et al. 1996; Nickel et al. 1997).
4. Chromosome region 6q22-q23.—This region con-
tains the gene, IFN-gR1, coding for the IFN-g receptor
ligand-binding chain, mutations in which are responsible
for major alterations in the granulomatous reaction to
nontuberculous mycobacteria causing severe dissemi-
nated infections (Jouanguy et al. 1996; Newport et al.
1996).
Linkage analysis performed with these four genetic
regions showed that SM2 maps to chromosome 6q22-
q23, suggesting that the IFN-gR1 gene itself may be
involved in the control of severe hepatic fibrosis due to
S. mansoni.
Subjects and Methods
Family Data
This study was conducted in Al Taweel, a small Su-
danese village of the Managil area at the southwestern
extension of the Gezira’s irrigated scheme, 300 km south
of Khartoum. All study subjects are migrants who settled
in the village ∼20 years ago, coming from the same re-
gion of western Sudan, where schistosomiasis is not en-
demic. Two tribes are present in the village: the Tama-
Messeria tribe (two-thirds of the population) and the
Rawashda tribe (one-third of the population), which are
closely related ethnic groups. The village was initially a
refugee camp that had been built in the middle of fields
where the villagers were employed. Various canals en-
circle the village, within a short distance (10–100 m)
from the houses, and the village is also crossed by a
small canal that is full 6 mo/year. These canals are pop-
ulated with snails infected by S. mansoni and are the
only source of water for drinking, domestic use (bathing
and washing), and agricultural use (irrigation of fields).
The socioeconomic status of Al Taweel’s families, as as-
sessed on the basis of dwellings, furniture, nutrition, and
domestic animals, is homogeneous. Information on fa-
milial relationships was obtained on the basis of several
interviews with family heads and their wives. Subjects
were also interviewed on the causes of death of their
recently deceased relatives, mostly parents. The 781 sub-
jects on whom ultrasound data were available belonged
to 65 families: 5 large pedigrees (30 members), 29
smaller pedigrees (6–29 members), and 31 nuclear fam-
ilies. Of the 65 families, 54 were from the Tama-Mes-
seria tribe, and 11 were from the Rawashda ethnic
group. This study was approved by medical-ethics com-
mittees of the University of Gezira and of Sudan’s Na-
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tional Ministry of Health. Informed consent was ob-
tained from the study subjects, who were free to leave
or to enter the study at any time.
Ultrasound Methods and Definition of the Severe
Fibrosis Phenotype
Study subjects were evaluated by ultrasound exami-
nation with a portable Aloka SSD 500 Echo camera and
a 3.5-MHz convex probe. Liver size, portal-vein diam-
eter (PVD), degree of periportal fibrosis, thickness of the
walls of peripheral portal branches (PPB), spleen size,
and splenic vein diameter were assessed as described else-
where (Homeida et al. 1988a, 1988b; The Cairo Work-
ing Group 1992). PVD was measured at the point of
the portal vein’s entrance into the porta hepatis, at the
lower end of the caudete lobe. Periportal fibrosis was
graded as 0–3 (F0–FIII). Grade 0 (F0) corresponds to
normal liver, with no thickening of the wall of the PPB.
In grade 1 (FI), there is a patchy fibrosis, which causes
a “fishes in the pond” appearance. The thickness of sec-
ond-order PPBs is ∼1 mm. Grade 2 (FII) corresponds to
continuous, in addition to patchy thickening of PPB
branches. Most second-order branches appear as long
segments of fibrosis that have ∼1-mm lumen and ∼2-
mm wall thickness. Gall-bladder wall thickness may be
increased above normal (2–4 mm). Grade 3 (FIII) shows
wall thickening of almost all PPBs. The fibrosis reaches
the surface of the liver, and, in some branches, the lumen
is occluded with second-order branches that have a wall
thickness 12 mm. Gall-bladder wall thickness is always
increased to 14 mm.
On the basis of ultrasound measurements, a binary
phenotype was used to classify the subjects as either
affected or unaffected. The criteria used for the classi-
fication were fibrosis grade and evidence of portal-blood
hypertension. Subjects with FIII were assigned to the
affected group, since previous studies have shown that
FIII patients have the most severe clinical manifesta-
tions—that is, bleeding (Homeida et al. 1988a, 1988b;
Richter et al. 1992a, 1992b; Domingues et al. 1993).
Four subjects who, during recent years, died from severe
schistosomiasis (diagnosed on the basis of hematemesis,
ascites, and lower-limb edema) also were included in the
affected group. Subjects with either F0 or FI were clas-
sified as unaffected because various clinical studies have
confirmed that these grades correspond to either no fi-
brosis or limited periportal fibrosis associated with the
mildest clinical forms of schistosomiasis. For the clas-
sification of the subjects with FII, additional echographic
informations was used, for two reasons: (1) FII has not
been systematically associated with severe clinical man-
ifestations (Richter et al. 1992a, 1992b; Domingues et
al. 1993), and (2) a second echographic evaluation per-
formed on 172 patients showed that FII subjects could
be misclassified whereas the classification of all FIII sub-
jects was confirmed by the second evaluation. For these
reasons, FII patients were assigned to the affected group
when they exhibited a PVD above a given threshold,
since increased PVD in schistosomiasis patients is a di-
rect indicator of portal-blood hypertension (Abdel-Latif
et al. 1981) and correlates with the occurrence of gas-
trointestinal bleeding (Richter et al. 1992a); this PVD
threshold was defined as the 95th percentile of the PVD
values observed in subjects with either F0 or FI. Since
PVD varies with age, five age-dependent thresholds were
defined: 110 mm (age 0–5 years), 111 mm (age 6–10
years), 112 mm (age 11–15 years), 114 mm (age 16–20
years), and 114 mm (age 120 years). FII patients with
a PVD lower than the age-specific threshold were clas-
sified as having an unknown phenotype.
Values for splenic-vein diameter and spleen volume
were comparable in the FII high-PVD group and in the
FIII group, for subjects 120 years of age (table 1).
Splenic-vein diameter and spleen size in these affected
subjects were increased compared with the values ob-
served in the FII group with normal PVD, whose values
themselves were close to those of groups F0 and FI (table
1). These observations further indicate portal-blood hy-
pertension in the subjects with an enlarged portal vein.
This classification is consistent with observations, by
others, that have indicated that the most frequent ultra-
sound findings in severe schistosomiasis are extended
periportal fibrosis, widening of portal and splenic veins,
and, eventually, splenomegaly (Cerri et al. 1984; Richter
et al. 1992a, 1992b). In contrast, liver volume was
smaller in affected subjects than in unaffected subjects;
this finding is explained by the shrinkage of the left lobe
in subjects with extended Symmers fibrosis.
Segregation Analysis
Segregation analysis was performed by the regressive
logistic model (Bonney 1986). This model specifies a
regression relationship between the probability of a per-
son being affected (i.e., having a severe fibrosis) and a
set of explanatory variables including major genotype,
phenotypes of antecedent individuals in the pedigree,
and other covariates.
The parameters of the major gene are (1) q, the fre-
quency of allele A predisposing to severe fibrosis, and
(2) aAA, aAa, and aaa, the three baseline risks of being
affected, on the logit scale corresponding to the three
genotypes, AA, Aa, and aa. To ensure that the parent-
offspring transmission of the major gene is Mendelian,
three additional parameters—tAA, tAa, and taa—have
been defined, which denote the probabilities of trans-
mission of A, for individuals with genotypes AA, Aa,
and aa, respectively. These parameters are used to test
the hypothesis of Mendelian transmission ( ,t = 1AA
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, and ) against alternative hypotheses sucht = .5 t = 0Aa aa
as general transmission (free t’s) and no parent-offspring
transmission (equal t’s).
The dependence on relative phenotypes is parame-
trized through regression coefficients accounting for the
relationship between the phenotype of an individual
and the phenotype of his antecedent relatives. In the
class D pattern of familial dependence, which is used
in the present analysis, four types of phenotypic fa-
milial dependencies are considered: spouse-spouse, fa-
ther-offspring, mother-offspring, and sib-sib. Since nei-
ther spouse-spouse dependence nor difference between
father-offspring and mother-offspring dependence was
found to be significant, results are presented with a
global parent-offspring parameter and a sib-sib regres-
sion parameter, which are denoted as “GPO” and “GSS,”
respectively. To account for unknown phenotypes, each
of the G parameters is a vector of two coefficients (De-
menais 1991)—that is, ) andG = (g g G =PO PO1 PO2 SS
); for example, for an individual, the logit of(g gSS1 SS2
being affected either is modified by either gPO1 or gPO2
or remains unchanged when his or her father is af-
fected, unaffected, or unobserved, respectively.
The effects of covariates are specified through regres-
sion coefficients. Of the covariates having effects on the
phenotype, those evaluated were gender (coded as “0”
for males and as “1” for females), age (in years), and
duration of exposure (in years). Since study subjects
began to settle in this village 20 years ago, the duration
of exposure was fixed at either 20 years, for subjects
20 years of age, or the subject’s age, for individuals
!20 years of age. Therefore, age and duration of ex-
posure were two highly correlated covariates, and the
best-fitting function was a simple regression on the du-
ration of exposure. Furthermore, the genotype #
covariate interactions were never found to be significant,
and, finally, the results of the present analysis are pre-
sented with two parameters, bsex and bdur, which are the
regression coefficients associated with sex and duration
of exposure, respectively.
All calculations were performed by the computer pro-
gram REGRESS (Demenais and Lathrop 1994), which
incorporates the regressive approach into the LINKAGE
package (Lathrop et al. 1984) and allows combined seg-
regation-linkage analysis (Bonney et al. 1988). No as-
certainment correction was needed for likelihood com-
putations, since all families of the village were included
in the analysis. Nested models were compared by means
of the likelihood-ratio test.
Linkage Analysis
Two-point LOD scores for various values of the re-
combination fraction (v) were computed by means of
the LINKAGE package and by use of the major-gene
model obtained from segregation analysis (20 liability
classes were defined according to gender and duration
of exposure considered in terms of 2-years intervals).
Marker-allele frequencies were estimated from our data,
since some alleles found in this Sudanese population
were not referred in the CEPH reference families. The
analysis was also performed under the assumption that
the marker-allele frequencies were equal. For marker
D6S310, a combined segregation-linkage analysis using
the REGRESS program was also performed. In this
case, linkage is tested by comparison of the maximum
likelihood obtained under a genetic model assuming no
linkage ( ) versus that obtained under the same ge-v = .5
netic model accounting for linkage (v estimated). This
combined analysis also allows a new estimation of ma-
jor-gene parameters in the presence of linkage. Multi-
point analysis was conducted by the VITESSE program
(O’Connell and Weeks 1995), which needed to simplify
two pedigrees and to break one loop. Because of both
the large size of some families and the number of marker
alleles (i.e., 5–13), calculations were confined to a five-
point analysis including the following four markers:
D6S1009, FA1, D6S310, and D6S308.
Genotyping
The potential role of four regions containing genes
that could be involved in the control of severe hepatic
fibrosis was investigated by linkage analysis with the
polymorphic markers indicated in table 2. Markers for
the 5q31-q33 region were as described elsewhere (Mar-
quet et al. 1996). Markers D12S92 and D6S1009 were
from the Ge´ne´thon panel (Dib et al. 1996), and the other
“D” markers were from the ABI PRISM Linkage Map-
ping Panel, version 1 (Perkin-Elmer). The FA1 marker
(GenBank) has been described by Altare et al. (1998),
and the TNF markers have been described by Cabrera
et al. (1995). Amplifications and PCR-product analysis
were performed as described by Marquet et al. (1996).
Results
Determining the Severe Hepatic Fibrosis Phenotype in
the Sudanese Study Subjects
The study was conducted in Al Taweel, a Sudanese
village highly endemic for S. mansoni, as are many vil-
lages in Gezira region (Omer et al. 1976). Detailed dem-
ographic, epidemiological, and clinical observations of
this village have been reported elsewhere (Mohamed-Ali
et al. 1999). The entire population of the village, ∼900
people, was studied, except for those subjects (∼13%)
who, because they were then traveling to remote areas,
were not available at the time of either the first or second
echographic evaluation. Of 781 subjects (361 males and
420 females) evaluated by ultrasound, 217, 460, 85, and
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Table 1
Mean  Standard Error of the Mean, of Ultrasound Measurements in 337 Subjects 120 Years of Age, According
to Affected Status
STATUS OF SUBJECTS
Unaffected:
FO or FIa
Affected
Unknown:
FIIcFIII FIIb All
No. of subjects 256 17 21 38 43
PVD (mm) 11.9  .09 15.1  .27 15.3  .17 15.2  .15 12.9  .18
Left-liver-lobe volume (cm3) 114.4  1.7 92.2  4.2 111.7  5.3 102.9  3.8 106.7  4.2
Splenic-vein diameter (mm) 7.6  .13 11.0  .51 10.4  .59 10.71  .40 8.2  .34
Spleen volume (cm3) 247.0  11.3 617.8  112.9 513.7  99.1 560.2  74.0 269.2  21.0
a Subjects with grade 0 or 1.
b Grade 2 subjects with PVD 114 mm.
c Grade 2 subjects with PVD 14 mm.
Table 2
Distribution of 781 Subjects Who Had Ultrasound
Measurements, by Age and Affection Status
AGE GROUP
(years)
NO. (%) OF SUBJECTS
Unaffecteda Affectedb Unknownc Total
!10 217 (96.9) 0 7 (3.1) 224
10–14 138 (93.9) 4 (2.7 ) 5 (3.4) 147
15–19 72 (92.3) 1 (1.3) 5 (6.4) 78
20–29 80 (71.4) 11 (9.8) 21 (18.8) 112
30–39 72 (82.7) 8 (9.2) 7 (8.1) 87
40–49 44 (71.0) 8 (12.9) 10 (16.1) 62
150 54 (76.1) 11 (15.5) 6 (8.4) 71
Total 677 (86.7) 43 (5.5) 61 (7.8) 781
a Subjects with grade 0 or 1.
b Grade 3 subjects and grade 2 subjects with PVD above age-
specific threshold.
c Grade 2 subjects with PVD below age-specific threshold.
19 exhibited grades 0, 1, 2, and 3, respectively; 24 FII
subjects had a PVD above their age-specific threshold
and were classified as affected, whereas the remaining
61 were considered as having an unknown phenotype
(table 1). Therefore, the total number of affected subjects
was 47 (19 FIII, 24 FII with high PVD, and 4 who died
of severe schistosomiasis), corresponding to 6% of the
evaluated individuals. This proportion was much higher
in males (41/361 [11.3%]) than in females (6/420
[1.4%]). The distribution of affected subjects, stratified
by age class, is shown in table 2; only five affected sub-
jects were !20 years of age. Of the five large pedigrees,
four included more than three affected subjects each,
whereas the remaining pedigree had no affected
members.
Detecting a Major Gene for Severe Fibrosis (SM2), by
Segregation Analysis
The results of segregation analysis are presented in
table 3. The hypothesis of no familial dependencies was
rejected (model I vs. model IIa; , 4 df,2x = 13.3 P !
), and the sib-sib dependence was not significant. The.02
most parsimonious model (model IIb) included only the
gP1 parameter, which, in this case, is directly interpretable
in terms of log odds ratio (Abel et al. 1993)—that is,
the odds ratio that compares the likelihood that a child
with an affected parent will be affected versus the like-
lihood that a child with an unaffected or an unknown
parent will be affected— . In the presenceexp(g ) = 4.26P1
of parent-offspring dependence, there was evidence for
a codominant major gene (model IIb vs. model IIIa;
, 3 df, ). Both the recessive (model IIIc2x = 12.1 P ! .01
vs. model IIIa) and the dominant (model IIIb vs. model
IIIa) hypotheses for the major-gene effect were rejected.
Parent-offspring dependence residual from the codom-
inant major gene (model IIId vs. model IIIa) was not
significant ( , 1 df, ). The Mendelian trans-2x = 0.3 P 1 .5
mission of the codominant major effect (Model IIId vs.
model Vb) was compatible with the data ( , 3 df,2x = 6.9
), whereas the estimate of tAA was far from itsP 1 .07
Mendelian value (i.e., it was .0 instead of 1); however,
it should be noted that tAA is not a critical parameter in
this analysis, since the expected proportion of AA in-
dividuals is very low (.008) under model Vb and fixing
tAA at 1 only increased the value of minus twice the log
likelihood (2logL) of model Vb by .8 (not shown in
table 3). Finally, the non–parent-offspring transmission
hypothesis (model Va vs. model Vb) was rejected ( 2x =
, 2 df, ). In conclusion, a codominant major14.6 P ! .007
gene referred to as “SM2” accounts for the familial dis-
tribution of the phenotype defined as hepatic fibrosis and
portal hypertension in schistosomiasis. The frequency of
the deleterious allele A was estimated as .162; conse-
quently, the respective proportions of AA, Aa, and aa
subjects were .03, .27, and .70.
Mapping SM2 to Chromosome 6q22-q23
To localize SM2, all informative families withmultiple
cases of severe fibrosis (i.e., eight families including 112
individuals) were genotyped, and linkage analysis was
Table 3
Results of Combined Segregation-linkage Analysis
MODEL AND HYPOTHESIS
VALUE OF PARAMETER
aAA aAa aaa b sex b dur q v tAA tAa taa gPo1 gPo2 gSS1 gSS2 2lnLc
a
I. Sporadic 7.26 (=aAA) (=aAA) 2.39 .31 (0) ) ) ) ) (0) (0) (0) (0) 37.0
II. Familial dependences:
a. All familial dependencies 9.02 (=aAA) (=aAA) 2.32 .39 (0) ) ) ) ) 1.38 .12 .20 .20 23.7
b. Parent-offspring ( )g = 0PO2 8.73 (=aAA) (=aAA) 2.32 .37 (0) ) ) ) ) 1.48 (0) (0) (0) 25.1
IV-1. Mendelian major gene, under the assumption of no linkage
with D6S310:
a. Codominant, residual familial dependencies 15.15 31.69 34.99 10.62 1.61 .165 (.5) (1) (.5) (0) .73 (0) (0) (0) 13.0
b. Dominant, residual familial dependencies 7.90 (=aAA) 10.96 3.01 .45 .075 (.5) (1) (.5) (0) 1.23 (0) (0) (0) 21.3
c. Recessive, residual familial dependencies 15.69 34.99 (=aAa) 12.14 1.68 .186 (.5) (1) (.5) (0) 1.19 (0) (0) (0) 18.5
d. Codominant, no residual familial dependencies 14.71 30.91 34.99 10.00 1.58 .162 (.5) (1) (.5) (0) (0) (0) (0) (0) 13.3
IV-2. Mendelian major gene accounting for linkage with D6S310,
codominant, no residual familial dependencies 13.94 29.03 33.82 7.67 1.50 .153 .0 (1) (.5) (0) (0) (0) (0) (0) .0
V. Non-Mendelian codominant major effect (under the assumption
of no linkage):
a. No vertical transmission 15.83 31.52 34.99 8.74 1.62 .084 (.5) .23 (=tAA) (=tAA) (0) (0) (0) (0) 21.0
b. General transmission 14.53 31.01 34.99 10.65 1.60 .087 (.5) .0 .68 .08 (0) (0) (0) (0) 6.4
a L = likelihood, and c = 2lnL of model IV-2.
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Table 4
LOD Scores at Various v Values for Linkage of SM2 to Four Candidate Regions
REGION AND MARKER (DISTANCEa)
LOD SCORE AT v =
.0 .01 .05 .10 .20 .30 .40
5q31-q33:
D5S471 11.20 6.57 3.90 2.52 1.12 .42 .09
IL4 (4a) 4.92 2.86 1.65 1.02 .42 .14 .03
D5S393 (10) 4.64 3.04 1.75 1.08 .44 .17 .05
D5S436 (17) .25 .20 .06 .03 .07 .03 .01
D5S636 (23) 5.84 3.37 2.21 1.50 .72 .32 .10
D5S2077 (26) 1.95 1.63 .89 .50 .20 .09 .04
D5S673 (27) 4.60 1.55 .81 .49 .23 .12 .05
D5S410 (27) 1.16 .68 .17 .02 .10 .06 .02
6q22-q23:
D6S292 1.40 1.27 .88 .57 .22 .07 .01
D6S1009 (2) 1.26 1.26 1.23 1.14 .84 .47 .15
FA1 (3) 1.80 1.76 1.58 1.35 .89 .47 .14
D6S310 (4) 2.81 2.74 2.46 2.10 1.37 .70 .20
D6S308 (5) .56 .50 .34 .21 .07 .02 .00
D6S441 (16) .80 .83 .91 .89 .66 .33 .07
6p21:
TNF 5.60 2.09 1.13 .67 .25 .09 .02
D6S276 (1) 2.50 2.35 1.81 1.29 .62 .24 .05
12q15:
D12S83 .34 .37 .43 .44 .33 .17 .05
D12S92 (8) 1.23 5.64 3.33 2.12 .92 .34 .07
D12S326 (11) 6.61 3.99 2.58 1.75 .84 .35 .09
a Approximate genetic distance (in cM) from the first marker listed for each region.
conducted in four candidate regions: (1) the 5q31-q33
region, where SM1 and several candidate genes—such
as those coding for the granulocyte-macrophage col-
ony–stimulating factor (CSF2), several interleukins (IL-
13, IL-3, IL-4, IL-5, IL-9, and IL-12), the interferon
regulatory factor 1 (IRF1), the colony-stimulating fac-
tor-1 receptor (CSF-1R), and the gene(s) controlling total
serum IgE levels and familial hypereosinophilia—are lo-
cated; (2) the HLA-TNF region (6p21), containing the
HLA locus and the TNF-a and TNF-b genes; (3) the
12q15 region, including the IFN-ggene and a gene con-
trolling total serum IgE levels; and (4) the 6q22-q23
region, containing the IFN-gR1 gene. Two-point LOD
scores are shown in table 4. No maximum LOD-score
(Zmax) values 1.1 were observed with any marker from
regions 5q31-q33 and 6p21. In the 12q15 region,
D12S83 provided a Zmax of .44 at , but multipointv = .08
analysis showed a LOD score !4 at a location cor-
responding to the gene coding for IFN-g. In contrast,
significant Zmax values were observed in region 6q22-
q23, with both D6S310 ( at ) and theZ = 2.81 v = .0max
FA1 intragenic marker ( at ). TheZ = 1.80 v = .0max
D6S308 marker was poorly informative, with a hetero-
zygosity of !60%. The use of equal marker-allele fre-
quencies did not strongly influence the results for
D6S310 and FA1, which had at andZ = 2.77 v = .0max
at , respectively. The segregation ofZ = 2.14 v = .0max
haplotypes for the six markers in this region in two
families is presented in figure 1.
To further investigate the linkage with the 6q22-q23
region, we performed a combined segregation-linkage
analysis with the D6S310 marker (table 3). Results
showed that the hypothesis of no linkage with D6S310
was highly rejected (model IIIa vs. model IV; 2x =
, 1 df, ). Under the model accounting for13.3 P ! .0003
linkage with D6S310, the maximum-likelihood estimate
of vwas .0, and the LOD score was 3.11. The parameters
of SM2 (i.e., penetrance and allele frequency) estimated
in this combined segregation-linkage analysis are very
close to those obtained under the assumption of no link-
age, and figure 2 shows the penetrance, with duration
of exposure, for AA subjects and Aa males, that is pre-
dicted by the model accounting for linkage. For AA sub-
jects the penetrance is almost complete after 12 and 17
years of exposure, for males and females, respectively,
whereas for Aa males the penetrance is .73 after 20 years
of exposure. For aa males the penetrance reaches .02
after 20 years of exposure and is !.01 before then; for
Aa and aa females the penetrance remains lower !.001
after 20 years of exposure.
We also conducted a five-point analysis using the VI-
TESSE program (fig. 3), which needed to simplify two
large pedigrees. The multipoint Zmax of 3.12 was ob-
tained with D6S310, and a LOD of 2.49 was observed
Figure 1 Segregation of the six markers of the 6q22-q23 region in two families, indicating, for each subject, the phenotype, age, and the haplotype minimizing the number of recombinants for
the six markers. Alleles inferred from other relatives are displayed in outline italic. The likely susceptibility haplotypes are boxed. Recombinations are indicated by arrowheads.
Dessein et al.: Genetics of Hepatic Fibrosis Due to S. mansoni 717
Figure 2 Penetrance, according to exposure time, predicted by
model IV of table 3, for AA subjects and Aa males.
Figure 3 Multipoint analysis showing the location of SM2 in
relation to the following four markers: D6S1009, FA1, D6S310, and
D6S308. The horizontal axis represents the genetic distance (in cM),
with the intragenic IFN-gR1 marker FA1 chosen as the origin.
with the FA1 intragenic marker. This precise location of
SM2 should be interpreted in light of the linkage results
that were obtained with SM2 parameters estimated un-
der the hypothesis of a single gene, whereas the true
genetic model could be more complex. In the latter case,
SM2 parameters could be partly misspecified, leading to
bias in the estimation of v (Clerget-Darpoux et al. 1986);
however, this possible misspecification does not influence
the robustness of the analysis (i.e., it does not lead to a
false conclusion with regard to linkage) and conse-
quently does not affect the validity of our findings show-
ing a linkage within the region 6q22-q23.
Discussion
The report of a major locus controlling susceptibility
to Symmers fibrosis brings considerable progress to our
understanding of why only a fraction of subjects infected
by S. mansoni develop severe fibrosis. Since hepatic fi-
brosis is the consequence of the inflammation induced
by eggs and worm products in the portal spaces, it has
been thought that disease development is dependent on
a patient’s worm load. This view has been supported by
reports indicating that hepatosplenomegaly is both more
frequent in areas of high endemicity (Kloetzel 1962;
Arap Siongok et al. 1976) and is correlated with infec-
tion levels (Cheever 1968; Cook et al. 1974) in endemic
populations; however, ultrasound examination have re-
vealed that high fibrosis grades are associated with high
infection only in children (Homeida et al. 1988a; Abdel-
Wahab et al. 1990; Doehring-Schwerdtfeger et al. 1990;
Domingues et al. 1993) and that hepatomegaly is not
necessarily associated with severe fibrosis (Homeida et
al. 1988a; Doehring-Schwerdtfeger et al. 1992; Richter
et al. 1992a). In the present Sudanese study, severe fi-
brosis (with hypertension) was associated with the du-
ration of infection (Mohamed-Ali et al. 1999). Taken
together, these observations indicate either that infection
intensity is probably not a major factor in disease de-
velopment or that its effects are hidden by the action of
more-important factors.Wemade no attempt to evaluate
exposure to infection in this Sudanese population, be-
cause advanced fibrosis developed 10–15 years after in-
fection, indicating that measurement (to be meaningful)
would have to be performed over a very long pe-
riod—and this was, in practice, impossible. Further-
more, we have previously shown that differences in ex-
posure account for no more than 20%–30% of
infection-intensity variance in a population whose mem-
bers have similar levels of water contact (Abel et al.
1991). This, together with the observation that infection
intensity is probably not a major factor in disease de-
velopment, makes it unlikely that exposure differences
between subjects in this population could be an impor-
tant determinant of severe fibrosis.
A characteristic of this study is that the present pop-
ulation migrated into this area 20 years ago, coming
from a nonendemic area. Therefore, it is unlikely that
study subjects had developed schistosomiasis disease or
immunity to disease previously and that selective pres-
sures have been exerted by S. mansoni infections on this
population. The genetic model indicates that a 50%pen-
etrance is reached after 9, 14, and 19 years of residency
in the area, for AA males, AA females, and Aa males,
respectively, whereas for other subjects the penetrance
remains !.02 after 20 years of exposure. Nevertheless,
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with a time of residence sufficiently long, all heterozy-
gote males are likely to present with the disease. Con-
sequently, in this population, 30% (i.e., 3% of homo-
zygotes and 27% of heterozygotes) of males could
potentially develop severe schistosomiasis if left un-
treated. It would now be interesting to determine
whether the same proportions will be recorded in pop-
ulations that have been living in endemic areas for longer
time periods. The estimated penetrance of SM2 strongly
depends on gender, accounting for the lower prevalence
of fibrosis in females than in males. Such gender differ-
ences in the prevalence of fibrosis cases have been re-
ported by other groups working either in Sudan (Hom-
eida et al. 1988a, 1988b) or in Egypt (Abdel-Wahab et
al. 1990). Elsewhere, we have shown that the low prev-
alence of FII and FIII in females is likely due to a sharp
decrease in the prevalence of infection in females 16
of age (Mohamed-Ali et al. 1999). This decrease might
be due either to a reduction in exposure after puberty
(after puberty, females in Muslim countries might be less
exposed to infection than are males) or to differences,
in the development of immunity, between males and
females.
Previously, we investigated the causes of high infection
levels by S. mansoni in an endemic Brazilian population,
and we found that, to a large extent, they depended on
a major gene, SM1 (Abel et al. 1991), which we mapped
to the 5q31-33 region (Marquet et al. 1996). This result
subsequently was confirmed in a Senegalese population
(Mu¨ller-Myhsok et al. 1997). Ongoing work is attempt-
ing to characterize this gene. The present report that the
major locus controlling fibrosis is not linked to chro-
mosome 5q31-33 and that it maps to another region
demonstrates that antidisease immunity and anti-infec-
tion immunity are under distinct major-gene control.
Obviously our results do not rule out an interaction
between SM1 and SM2. It is reasonable to postulate that
disease development is accelerated in SM2 subjects pre-
disposed to high infections. Unfortunately, the low and
rather uniform levels of infection in our study population
did not allow us either to search for SM1 or to evaluate
possible interactions between SM1 and SM2. Our link-
age results obtained with two microsatellite markers of
the HLA-TNF region also indicate that the major locus
SM2 is very unlikely to be located within this region,
whereas associations have been reported between (a)
some HLA class I alleles (A1 and B5) and hepatosplen-
omegaly in Egypt (Salam et al. 1979; Abaza et al. 1985;
Abdel-Salam et al. 1986) and (b) an HLA class II allele
(DQB1*0201) and biopsy-confirmed hepatic schistoso-
miasis in Brazil (Secor et al. 1996). However, it should
be stressed that the present results do not exclude the
role of additional polymorphisms, such as specific HLA
antigens, which could be detected by an appropriate as-
sociation study in this population.
It is too early to speculate on the mechanism of action
of SM2; however, given the results of multipoint linkage
analysis, which maps the susceptibility locus close to the
IFN-gR1 gene, polymorphism(s) in this IFN-g receptor
may account for increased susceptibility to severe fibro-
sis. This hypothesis is consistent with reports in exper-
imental models showing that IFN-g is the major anti-
fibrogenic cytokine in the schistosome granuloma (Czaja
et al. 1989a). In addition, human IFN-g has been shown
to inhibit proliferation of human fibroblasts (Duncan
and Berman 1985), to down-regulate both collagen
(Duncan and Berman 1985) and prolyl 4-hydroxylase
biosynthesis (Kawaguchi et al. 1992), and to stimulate
the synthesis of metalloproteases (collagenases) (Tamai
et al. 1995). More specifically, IFN-g inhibits prolifer-
ation and down-regulates collagen biosynthesis by Ito
cells (Mallat et al. 1995), which are the major source of
collagen in the liver of schistosome-infected subjects.
Various works have also shown that tissue fibrosis can
be reduced by injections of IFN-g (Granstein et al. 1990;
Hein et al. 1992). Finally, recent works have shown that
mutations in the IFN-gR1 gene can dramatically alter
susceptibility to infectious diseases such as nontuber-
culous mycobacterial infections (Jouanguy et al. 1996;
Newport et al. 1996)
In conclusion, this work shows that severe fibrosis in
subjects infected by S. mansoni is determined by a major
locus that maps close to the IFN-gR1 gene. This finding
opens the way to both the identification of the gene and
the evaluation of its role in the determination of ab-
normal fibrosis of other etiological origins. Finally, our
results will stimulate new strategies in drug and vaccine
development.
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